Atlas Trials

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

Clinical trial NCT03303170 · COMPLETED

Trial details

NCT number
NCT03303170
Sponsor
Sebacia, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2017-09-25
Primary completion
2018-04-10
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.